Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis [Phase 2]

View source ↗

Summary

Phase 2 trial to evaluate the safety and efficacy of SM-020 Gel 1.0% for seborrheic keratosis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seborrheic Keratosis

Drugs mentioned

• SM-020 Gel 1.0% (SM-020)

Snippet

Sponsor: DermBiont, Inc. | Conditions: Seborrheic Keratosis | Phase 2 | Status: RECRUITING